At Cellistic, iPSC scale-up isn’t a flavor-of-the-day. It’s a first language. It’s a promise waiting to be kept. It’s how the next generation of allogeneic cell therapy innovators will improve patients’ lives everywhere. And it’s all driven here by a team with deep, diverse expertise in the business and science of cell therapy.
Gustavo Mahler, PhD
Chief Executive Officer
Stefan Braam, PhD
Chief Technical Officer
Jonas Mortensen
Chief Commercial Officer
Charles Jacques
Chief Financial Officer
Astrid Norenberg, PhD
Head of Project Management
Suzanne Snellenberg, PhD
Vice President Cell Line Development
John Barlow, PhD
Analytical Development Director
Vincent Ernst
Quality Assurance Director & QP
Eric Mathieu
Senior Vice President Operations
Vincent Mancuso
Vice President Operations